Holen Sie sich die Stockscreener-App
4.01
2.56%
0.10
Handel nachbörslich:
3.99
-0.02
-0.50%
Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1,727%
0.244
|
-0.015 | 0.234 | 0.183 | 0.084 |
Operating Expenses
|
10.83%
16.05
|
14.48 | 15.35 | 14.41 | 12.21 |
| Benefits Costs and Expenses |
12.62%
15.34
|
13.62 | 14.32 | 13.14 | 10.82 |
| Costs And Expenses |
12.62%
15.34
|
13.62 | 14.32 | 13.14 | 10.82 |
| Operating Income/Loss |
9.03%
-15.80
|
-14.49 | -15.12 | -14.23 | -12.13 |
| Income/Loss From Continuing Operations Before Tax |
10.71%
-15.10
|
-13.63 | -14.09 | -12.95 | -10.73 |
| Income Tax Expense/Benefit |
-
|
- | - | 0.007 | - |
| Income/Loss From Continuing Operations After Tax |
10.71%
-15.10
|
-13.63 | -14.09 | -12.96 | -10.73 |
|
Net Income/Loss
|
10.71%
-15.10
|
-13.63 | -14.09 | -12.96 | -10.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
13,927%
31.93
|
0.2276 | 30.71 | 30.63 | 30.60 |
| Diluted Average Shares |
13,927%
31.93
|
0.2276 | 30.71 | 30.63 | 30.60 |
| Basic Earnings Per Share |
6.82%
-0.47
|
-0.44 | -0.46 | -0.42 | -0.35 |
| Diluted Earnings Per Share |
6.82%
-0.47
|
-0.44 | -0.46 | -0.42 | -0.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):